1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30931
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWight, Joel C-
dc.contributor.authorHamad, Nada-
dc.contributor.authorCampbell, Belinda A-
dc.contributor.authorKu, Matthew-
dc.contributor.authorLee, Kenneth-
dc.contributor.authorRose, Hannah-
dc.contributor.authorArmytage, Tasman-
dc.contributor.authorLatimer, Maya-
dc.contributor.authorLee, Hui-Peng-
dc.contributor.authorLee, Sze Ting-
dc.contributor.authorDickinson, Michael-
dc.contributor.authorKhor, Richard-
dc.contributor.authorVerner, Emma-
dc.date2022-
dc.date.accessioned2022-09-20T06:52:16Z-
dc.date.available2022-09-20T06:52:16Z-
dc.date.issued2022-09-
dc.identifier.citationInternal medicine journal 2022; 52(9): 1609-1623en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30931-
dc.description.abstractDiffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype, accounting for 30-40% of lymphoma diagnoses. Although aggressive, cure is achievable in approximately 60% of cases with primary chemoimmunotherapy, and in a further substantial minority by salvage therapy and autologous stem cell transplantation. Despite promising activity in early phase clinical trials, no intensified or novel treatment regimen has improved outcomes over R-CHOP21 in randomised studies. However, there remain several areas of controversy including the most appropriate prognostic markers, central nervous system prophylaxis and the optimal treatment for patients with high-risk disease. This position statement presents an evidence-based synthesis of the literature for application in Australasian practice.en_US
dc.language.isoeng
dc.subjectdiagnosisen_US
dc.subjectdiffuse large B-cell lymphomaen_US
dc.subjectmanagementen_US
dc.subjectprognosisen_US
dc.titleDiffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternal medicine journalen_US
dc.identifier.affiliationDepartment of Haematology and Bone Marrow Transplantation, Townsville University Hospital, Townsville, Queensland, Australia.. Department of Haematology, Austin Health, Melbourne, Victoria, Australia.. School of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.. School of Medicine, James Cook University, Townsville, Queensland, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.. School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia.. St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia..en_US
dc.identifier.affiliationDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.. Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.. Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia..en_US
dc.identifier.affiliationSchool of Medicine, University of Sydney, Sydney, New South Wales, Australia.. Anatomical Pathology Department, NSW Health Pathology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, University Hospital, Geelong, Victoria, Australia.. School of Medicine, Deakin University, Geelong, Victoria, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, Gosford Hospital, Gosford, New South Wales, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.. Department of Haematology, Australian National University, Canberra, Australian Capital Territory, Australia..en_US
dc.identifier.affiliationDepartment of Haematology, Flinders Medical Centre, Adelaide, South Australia, Australia..en_US
dc.identifier.affiliationSchool of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.. Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.. Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..en_US
dc.identifier.affiliationClinical Haematologyen_US
dc.identifier.affiliationSchool of Medicine, University of Sydney, Sydney, New South Wales, Australia.. Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia..en_US
dc.identifier.doi10.1111/imj.15533en_US
dc.type.contentTexten_US
dc.identifier.orcidhttps://orcid.org/0000-0002-3216-2392en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-7929-1450en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-9289-1335en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-8641-456Xen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-1492-5966en_US
dc.identifier.pubmedid34532916
local.name.researcherKhor, Richard
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

74
checked on Nov 6, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.